TABLE 2.

BCL1‐TLA and BCL2‐TLA positive samples description

Sample	Tissue analyzed	Tumor infiltration (%)	Sanger	TLA	chr11 start  (genome position)	chr11 end  (genome position)	bp at 3'side: CCND1	chr14 start  (genome position)	chr14 end  (genome position)	JH
TLA2	BM	60	IGH	BCL1‐TLA	69640529	69641063	251	105863253	105862668	JH6
TLA3	BM	65	IGH	BCL1‐TLA	69503685	69504229	137407	105863690	105864253	JH5
TLA4	PB	70	IGH	BCL1‐TLA	69598743	69599273	42039	105863690	105864254	JH5
TLA5	PB	71	IGH	BCL1‐TLA	69552333	69552869	88500	105863692	105864257	JH4
TLA6	PB	26	IGH	BCL1‐TLA	69643001	69543547	97767	105863300	105863863	JH5
TLA7	BM	52	IGH	BCL1‐TLA	69639411	69639966	1348	105863691	105864263	JH4
TLA8	BM	17	IGH	BCL1‐TLA	69572005	69572592	68720	105864605	105865113	JH3
TLA9	PB	78	IGH	BCL1‐TLA	69624506	69624809	16269	105860944	105861521	JH6
TLA10	PB	95	IGH	BCL1‐TLA	69598743	69599274	98266	105863792	105863852	JH5
TLA11	PB	56.5	IGH	BCL1‐TLA	69636004	69636505	4809	105859639	105860261	JH6
TLA12	BM	78	IGH	BCL1‐TLA	69609945	69610445	30869	105863697	105864249	JH5
TLA13	BM	59	no marker	BCL1‐TLA	69585008	69585564	55750	105863301	105863862	JH5
TLA16	PB	73	no marker	BCL1‐TLA	69624288	69624349	16965	105863190	105863251	JH6
TLA19	PB	6,5	IGH	BCL1‐TLA	69564262	69564303	77011	105865357	105865449	JH1
TLA20	BM	11	no marker	BCL1‐TLA	69624289	69624362	16965	105864193	105864252	JH4
TLA21	BM	35	no marker	BCL1‐TLA	69530667	69530724	110590	105865413	105865458	JH1

Sample	Tissue analyzed	Sanger	TLA	chr18 start  (genome position)	chr18 end  (genome position)	bp at 3'side: Bcl2	chr14 start  (genome position)	chr14 end  (genome position)	JH
TLA23	BM	No marker	BCL2‐TLA	63126356	63126264	2269	105863148	105863114	JH6
TLA25	BM	No marker	BCL2‐TLA	63124949	63124866	3676	105914386	105914359	DH3‐3
TLA26	BM	No marker	BCL2‐TLA	63107660	63107635	20956	105863252	105863144	JH6
TLA27	BM	No marker	BCL2‐TLA	63125450	63125411	3175	105863239	105863130	JH6
TLA29	BM	No marker	BCL1‐TLA	63120103	63120041	8522	105886030	105885959	DH3‐3